Sara Traini
Overview
Explore the profile of Sara Traini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
233
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ronchi G, Iorio M, Serroni A, Caporale M, Testa L, Palucci C, et al.
Vaccines (Basel)
. 2025 Jan;
12(12.
PMID: 39771964
Lumpy skin disease virus ( family- genus) is the aetiological agent of LSD, a disease primarily transmitted by hematophagous biting, affecting principally cattle. Currently, only live attenuated vaccines are commercially...
2.
Spedicato M, Ronchi G, Profeta F, Traini S, Capista S, Leone A, et al.
Virus Res
. 2024 Jun;
347:199416.
PMID: 38897236
Epizootic haemorrhagic disease (EHD), caused by the EHD virus (EHDV), is a vector-borne viral disease transmitted through Culicoides biting midges. EHDV comprises seven serotypes (1, 2, and 4-8), with EHDV-8...
3.
Serroni A, Traini S, Iorio M, Mangone I, Di Gialleonardo L, Molini U, et al.
Microbiol Resour Announc
. 2023 Mar;
12(4):e0103422.
PMID: 36920210
In this report, we describe eight complete genome sequences of African horse sickness virus (AHSV) strains belonging to four different serotypes, namely, AHSV-5, AHSV-6, AHSV-8, and AHSV-9. Samples were collected...
4.
Giagu A, Penati M, Traini S, Dore S, Addis M
Vet Res Commun
. 2022 Feb;
46(2):329-351.
PMID: 35195874
Mastitis is one of the most impacting diseases in dairy farming, and its sensitive and specific detection is therefore of the greatest importance. The clinical evaluation of udder and mammary...
5.
Pugliese D, Privitera G, Rogai F, Variola A, Viola A, Laterza L, et al.
United European Gastroenterol J
. 2020 Nov;
9(1):102-109.
PMID: 33203342
Background: Few data exist regarding the long-term effectiveness of golimumab in ulcerative colitis. No data have been reported on real-world continuous clinical response. Objective: This study aimed to describe the...
6.
Cantu P, Parzanese I, Balassone V, Di Sario A, Soggiu F, Lombardi G, et al.
Liver Transpl
. 2016 Dec;
23(2):257-261.
PMID: 28006872
No abstract available.
7.
Tarantino G, Bagnarelli P, Marzioni M, Marinelli K, Surace G, Traini S, et al.
Dig Liver Dis
. 2016 Aug;
48(11):1340-1345.
PMID: 27476463
Background: Recent data showed an increasing number of "autochthonous" cases of hepatitis E in Italy. Aims: Analysing cases of acute hepatitis E to define frequency, clinical features, prognosis and risk...
8.
Traini S, Piccolo E, Tinari N, Rossi C, La Sorda R, Spinella F, et al.
Mol Cancer Ther
. 2014 Feb;
13(4):916-25.
PMID: 24552775
Accumulating evidence indicates that serum and tissue levels of lectin, galactoside-binding soluble 3 binding protein (LGALS3BP), a secreted glycoprotein, are elevated in human cancers. Recently, we have identified LGALS3BP as...
9.
Sala G, Rapposelli I, Ghasemi R, Piccolo E, Traini S, Capone E, et al.
Transl Oncol
. 2014 Jan;
6(6):676-84.
PMID: 24466370
ErbB-3 (HER-3) receptor is involved in tumor progression and resistance to therapy. Development of specific inhibitors impairing the activity of ErbB-3 is an attractive tool for cancer therapeutics. MP-RM-1, a...
10.
Piccolo E, Tinari N, Semeraro D, Traini S, Fichera I, Cumashi A, et al.
J Mol Med (Berl)
. 2012 Aug;
91(1):83-94.
PMID: 22864925
Elevated serum or tissue levels of lectin galactoside-binding soluble 3 binding protein (LGALS3BP) have been associated with short survival and development of metastasis in a variety of human cancers. However,...